DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award
ID: 354994Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award (CSCCA) for innovative cancer research initiatives. This grant aims to foster transdisciplinary collaborations among scientists, clinicians, and consumer advocates to address complex cancer challenges, requiring applicants to focus on at least three distinct cancer types and align their proposals with the overarching challenges of the FY24 Peer Reviewed Cancer Research Program (PRCRP). The initiative emphasizes the integration of diverse disciplines to enhance cancer prevention, diagnosis, treatment, and quality of life, particularly benefiting service members and their families. The estimated total program funding is $32 million, with a minimum budget of $20 million expected for successful proposals, and key deadlines include Pre-Application submissions by July 24, 2024, and Full Applications by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Defense (DOD) is offering funding for the FY24 Peer Reviewed Cancer Research Program, specifically through the Convergent Science Cancer Consortium Award (CSCCA). This initiative seeks collaborative applications focused on significant cancer research that addresses at least three designated cancer types while also aligning with military health focus areas. Key submission deadlines include Pre-Application submissions by July 24, 2024, and Full Applications by October 15, 2024. The funding is aimed at improving cancer outcomes for service members, their families, and the broader public, with particular emphasis on advancing research in areas with gaps regarding early detection, prevention, and survivorship. A minimum budget of $20M is expected for successful proposals, with awards anticipated by September 2025. Eligible applicants include various organizations, both domestic and foreign, which can submit applications through two portals. The program underscores the importance of consumer advocate involvement and emphasizes a convergent science approach to overcome complex cancer challenges. The overarching aim is to promote innovative, transdisciplinary cancer research that ultimately enhances the quality of life for affected individuals and contributes to military readiness.
    Similar Opportunities
    DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity titled "DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award" for Fiscal Year 2024. This funding initiative aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment and management, particularly for military personnel and their families, addressing specific topic areas related to military health. With an estimated total program funding of $24 million and the expectation of awarding up to five grants, eligible applicants can submit proposals that demonstrate the feasibility and relevance of their clinical trials, with a maximum award amount of $3 million. Interested parties must submit their applications by October 15, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer, Virtual Cancer Center Director Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY24 Peer Reviewed Cancer Virtual Cancer Center Director Award (VCCDA), aimed at enhancing collaborative cancer research relevant to military health. This grant opportunity seeks experienced cancer researchers to lead a virtual cancer center that will support early-career investigators, fostering mentorship and innovative approaches to cancer research through convergent science. With an estimated total program funding of approximately $2.8 million and a budget cap of $1.75 million for individual applications, interested applicants must submit a pre-application by July 24, 2024, and a full application by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Kidney Cancer, Translational Research Partnership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Kidney Cancer Translational Research Partnership Award, a federal grant aimed at fostering collaborative research partnerships between clinicians and research scientists to advance kidney cancer treatment and care. This opportunity encourages the development of translational research projects that address significant problems in kidney cancer, requiring partnerships that include one clinician and one research scientist who contribute equally to the research design and execution. With an estimated total program funding of $7.68 million, the program anticipates awarding approximately six grants, each with a maximum budget of $800,000 over a three-year period. Interested applicants must submit a pre-application letter of intent by September 24, 2024, followed by a full application due by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the Fiscal Year 2024 Kidney Cancer Research Program (KCRP) Clinical Trial Award, aimed at supporting innovative clinical trials that can significantly impact kidney cancer treatment and management. The program encourages proposals that range from preliminary proof-of-concept trials to large-scale studies, emphasizing the need for robust preliminary data, access to suitable patient populations, and necessary materials for the trials. With an estimated total program funding of $6.4 million and the expectation of awarding approximately two grants, interested applicants must submit a pre-application letter of intent by September 24, 2024, and a complete application by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Kidney Cancer Research Program's Idea Development Award, aimed at advancing innovative and high-impact kidney cancer research. This grant opportunity encourages projects that align with strategic goals such as enhancing understanding of kidney cancer biology, developing novel therapies, and addressing healthcare disparities, with a focus on benefiting active-duty military personnel, veterans, and the general public. The total estimated funding for this program is approximately $18.56 million, with around 13 awards anticipated, and key deadlines include a pre-application due by September 24, 2024, and a full application deadline of October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Academy of Kidney Cancer Investigators - Early-Career Scholar Award, aimed at fostering innovative kidney cancer research by supporting early-career scholars. This program encourages applicants to develop research projects that address critical areas in kidney cancer biology, novel therapies, and healthcare disparities, while providing intensive mentoring and networking opportunities within a collaborative Academy environment. With an estimated total program funding of $2.32 million, the initiative anticipates awarding approximately two grants, with applications due by October 15, 2024, following a pre-application letter of intent due by September 24, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Reconstructive Transplant Research, Investigator-Initiated Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY24 Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award, aimed at advancing reconstructive transplant research and improving healthcare for military service members and veterans. This grant opportunity seeks proposals that focus on vascularized composite allotransplantation (VCA) and immunotherapy, emphasizing the optimization of immunosuppressive techniques, identification of noninvasive biomarkers for graft rejection monitoring, and development of tissue preservation strategies. With an estimated total program funding of $4 million, individual principal investigator applications can receive up to $1 million, while multiple principal investigator collaborations may secure up to $1.5 million, contingent upon successful peer review. The pre-application deadline is August 7, 2024, and the full application deadline is October 23, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Reconstructive Transplant, Idea Discovery Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Reconstructive Transplant Idea Discovery Award, a federal grant aimed at supporting innovative and high-risk research in reconstructive transplant and immunotherapy. This grant seeks to generate robust data that can lead to new scientific investigations, particularly focusing on enhancing immunosuppression techniques and advancing tissue preservation strategies relevant to military personnel and veterans. With an estimated total program funding of $2.5 million, the award will provide up to $500,000 for each selected project over a two-year period, contingent upon the availability of federal funds and the merit of applications. Interested applicants must submit a pre-application by August 7, 2024, followed by a full application due by October 23, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Arthritis Research, Clinical Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Arthritis Research Clinical Research Award (ATRP CRA) to support clinical research aimed at improving the understanding and management of various forms of arthritis, particularly in military personnel and their families. This grant program encourages innovative research proposals that address disease-specific factors and interventions, with a focus on enhancing patient outcomes and informing clinical care or policy. With an estimated total funding of $6 million, the program anticipates awarding approximately three grants, including one for a clinical trial, with applications due by October 30, 2024, and a pre-application deadline of October 16, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.